Cargando…

MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis

Endocrine resistance and metastatic progression are primary causes of treatment failure in breast cancer. While mitogen activated protein kinases (MAPKs) are known to promote ligand-independent cell growth, the role of the MEK5-ERK5 pathway in the progression of clinical breast carcinoma remains poo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antoon, James W., Martin, Elizabeth C., Lai, Rongye, Salvo, Virgilo A., Tang, Yan, Nitzchke, Ashley M., Elliott, Steven, Nam, Seung Yoon, Xiong, Wei, Rhodes, Lyndsay V., Collins-Burow, Bridgette, David, Odile, Wang, Guandi, Shan, Bin, Beckman, Barbara S., Nephew, Kenneth P., Burow, Matthew E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739787/ https://www.ncbi.nlm.nih.gov/pubmed/23950888 http://dx.doi.org/10.1371/journal.pone.0069291

Ejemplares similares

Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition
por: ANTOON, JAMES W., et al.
Publicado: (2013)

microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity
por: Martin, Elizabeth C, et al.
Publicado: (2014)

Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer
por: Matossian, Margarite D., et al.
Publicado: (2021)

Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
por: Antoon, James W., et al.
Publicado: (2012)

Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer
por: Rhodes, Lyndsay V., et al.
Publicado: (2015)

Human Mesenchymal Stem Cells as Mediators of Breast Carcinoma Tumorigenesis and Progression
por: Rhodes, Lyndsay V., et al.
Publicado: (2010)

Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk
por: Rhodes, Lyndsay V, et al.
Publicado: (2010)

Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation
por: Conger, Adrienne K., et al.
Publicado: (2016)

Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype
por: Zhou, Changhua, et al.
Publicado: (2008)

Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line
por: Martin, Elizabeth C., et al.
Publicado: (2012)

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
por: Tate, Chandra R, et al.
Publicado: (2012)

Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways
por: Strong, Amy L, et al.
Publicado: (2013)

Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration
por: Zhou, Changhua, et al.
Publicado: (2012)

Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells
por: Matossian, Margarite D., et al.
Publicado: (2021)

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer
por: Hoang, Van T., et al.
Publicado: (2020)

56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer
por: Nguyen, Khoa, et al.
Publicado: (2021)

The MEK5/ERK5 Pathway in Health and Disease
por: Paudel, Rupesh, et al.
Publicado: (2021)

GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies
por: Nguyen, Khoa, et al.
Publicado: (2022)

235 Analysiss of TNBC Cell Lines Cultured a Novel Translational Breast Cancer Microphysiological System (BC-MPS)
por: Hebert, Katherine L., et al.
Publicado: (2022)

Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress
por: Tusa, Ignazia, et al.
Publicado: (2023)

MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation
por: Craig, Jane E., et al.
Publicado: (2020)

Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling
por: Bhatt, Akshita B., et al.
Publicado: (2021)

miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling
por: Martin, Elizabeth C., et al.
Publicado: (2014)

Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy
por: Dong, Shengli, et al.
Publicado: (2023)

Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models
por: Sabol, Rachel A., et al.
Publicado: (2019)

Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer
por: Bhatt, Akshita B., et al.
Publicado: (2021)

Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1
por: Rhodes, L V, et al.
Publicado: (2015)

Induction of HOXA9 expression in three-dimensional organotypic culture of the Claudin-low breast cancer cells
por: Li, Miao, et al.
Publicado: (2016)

436 Examining the Role of Obesity and Leptin Signaling in Triple Negative Breast Cancer
por: Brock, Courtney, et al.
Publicado: (2022)

MEK5/ERK5 Signaling Modulates Endothelial Cell Migration and Focal Contact Turnover
por: Spiering, Désirée, et al.
Publicado: (2009)

MEK5/ERK5 activation regulates colon cancer stem-like cell properties
por: Pereira, Diane M., et al.
Publicado: (2019)

The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells
por: Tusa, Ignazia, et al.
Publicado: (2021)

MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
por: Fukasawa, Kazuya, et al.
Publicado: (2023)

Obesity-Altered Adipose Stem Cells Promote ER(+) Breast Cancer Metastasis through Estrogen Independent Pathways
por: Sabol, Rachel A., et al.
Publicado: (2019)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
por: Matossian, Margarite D., et al.
Publicado: (2019)

Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer
por: Sánchez-Fdez, Adrián, et al.
Publicado: (2021)

Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model
por: Matossian, Margarite D., et al.
Publicado: (2018)

Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment
por: Nguyen, Khoa, et al.
Publicado: (2021)

MAGOH/MAGOHB Inhibits the Tumorigenesis of Gastric Cancer via Inactivation of b-RAF/MEK/ERK Signaling
por: Zhou, Yong, et al.
Publicado: (2020)

SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling
por: Bao, Fan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4bg575c032amga9bm5ktlraoaf